Abstract
In the present study, the interaction of the novel synthesized platinum complex named methyl-glycine 1,10-phenanthroline platinum nitrate product with two most crucial blood carrier proteins of hemoglobin (Hb) and human serum albumin (HSA) has been investigated. Notably, structural alternation ability of the above anticancer compound was assessed at various temperatures through multispectroscopic techniques such as far-UV circular dichroism (CD) and fluorescence with the participation of the molecular docking targeting Hb and HSA in the systems of the medicine delivery. Fluctuations in the inherent fluorescence intensities of the proteins in consequence of the Pt(II) complex binding represented statics of the quenching system. It should be mentioned that thermodynamic and binding parameters have been calculated through the analysis of the outcomes of the quenching and outcomes of van’t Hoff equation for the two proteins. Theoretical and experimental findings pointed out that the leading force for the Pt(II) complex interaction was electrostatic for HSA and hydrophobic interactions for Hb. Moreover, fluorescence experiments discovered that one binding site would be available because of the Pt(II) complex binding in the two proteins accompanied by a negative Gibbs free energy value. Additionally, the far-UV CD outputs suggested that the Pt(II) complex would cause some variations in the regular secondary and tertiary structures of the HSA as the remarkable going down in the α helical contents of proteins structures at different temperatures equal to 25 °C and 37 °C; however, any noteworthy modifications have not been seen in the respective structures of Hb. However, the interaction between the newly made-up medicine (Pt(II) complex) and the two most crucial blood carrier proteins of the Hb and HSA made a notable shifting in the structures and conformations of the proteins via many fluctuations in the secondary and tertiary structures of the two proteins. Hence, such researches of designing the novel metal anticancer medicines may gather useful data for exploring the more suitable path in the face-off with severe disorders like various cancers through inventing and developing metal medical compounds that are more advantageous and have fewer consequences.
Graphic abstract
Similar content being viewed by others
References
M.K. Safo, M.H. Ahmed, M.S. Ghatge, T. Boyiri, Hemoglobin–ligand binding: understanding Hb function and allostery on atomic level. Biochim. Biophys. Acta Proteins Proteom. 1814(6), 797–809 (2011)
F. Ding, B.-Y. Han, W. Liu, L. Zhang, Y. Sun, Interaction of imidacloprid with hemoglobin by fluorescence and circular dichroism. J. Fluoresc. 20(3), 753–762 (2010)
A. Deep, Y. Kumar, P. Syal, S. Kumar, Method for non-invasive hemoglobin determination. Measurement (Lab-Hb), 7(3), 1–8 (2019)
C. Thomas, A.B. Lumb, Physiology of haemoglobin. BJA Educ. 12(5), 251–256 (2012)
C. Helms, D.B. Kim-Shapiro, Hemoglobin-mediated nitric oxide signaling. Free Radic. Biol. Med. 61, 464–472 (2013)
G. Fanali, A. Di Masi, V. Trezza, M. Marino, M. Fasano, P. Ascenzi, Human serum albumin: from bench to bedside. Mol. Asp. Med. 33(3), 209–290 (2012)
M. Maciążek-Jurczyk, A. Szkudlarek, M. Chudzik, J. Pożycka, A. Sułkowska, Alteration of human serum albumin binding properties induced by modifications: a review. Spectrochim. Acta A Mol. Biomol. Spectrosc. 188, 675–683 (2018)
M.T. Larsen, M. Kuhlmann, M.L. Hvam, K.A. Howard, Albumin-based drug delivery: harnessing nature to cure disease. Mol. Cell Ther. 4(1), 3 (2016)
M. Rezaei-Tavirani, S.H. Moghaddamnia, B. Ranjbar, M. Amani, S.-A. Marashi, Conformational study of human serum albumin in pre-denaturation temperatures by differential scanning calorimetry, circular dichroism and UV spectroscopy. BMB Rep. 39(5), 530–536 (2006)
S. Tayyab, M.M. Izzudin, M.Z. Kabir, S.R. Feroz, W.-V. Tee, S.B. Mohamad et al., Binding of an anticancer drug, axitinib to human serum albumin: fluorescence quenching and molecular docking study. J. Photochem. Photobiol. B 162, 386–394 (2016)
R. dos Santos, C. Figueiredo, A.C. Viecinski, A.S. Pina, A.J. Barbosa, A.C.A. Roque, Designed affinity ligands to capture human serum albumin. J. Chromatogr. A 1583, 88–97 (2019)
M.Z. Kabir, A.K. Mukarram, S.B. Mohamad, Z. Alias, S. Tayyab, Characterization of the binding of an anticancer drug, lapatinib to human serum albumin. J. Photochem. Photobiol. B 160, 229–239 (2016)
B. Elsadek, F. Kratz, Impact of albumin on drug delivery—new applications on the horizon. J. Control Release 157(1), 4–28 (2012)
F. Kratz, Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. J. Control Release 132(3), 171–183 (2008)
Y. Gou, Z. Zhang, D. Li, L. Zhao, M. Cai, Z. Sun et al., HSA-based multi-target combination therapy: regulating drugs’ release from HSA and overcoming single drug resistance in a breast cancer model. Drug Deliv. 25(1), 321–329 (2018)
B. Rosenberg, L. VanCamp, J.E. Trosko, V.H. Mansour, Platinum compounds: a new class of potent antitumour agents. Nature. 222(5191), 385–386 (1969)
Q. Mi, S. Shu, C. Yang, C. Gao, X. Zhang, X. Luo et al., Current status for oral platinum (IV) anticancer drug development. Radiat. Oncol. 7, 231–247 (2018)
T. Falta, G. Koellensperger, A. Standler, W. Buchberger, R.M. Mader, S. Hann, Quantification of cisplatin, carboplatin and oxaliplatin in spiked human plasma samples by ICP–SFMS and hydrophilic interaction liquid chromatography (HILIC) combined with ICP–MS detection. J. Anal. At. Spectrom. 24(10), 1336–1342 (2009)
L. Messori, A. Merlino, Cisplatin binding to proteins: a structural perspective. Coord. Chem. Rev. 315, 67–89 (2016)
G. Ferraro, L. Massai, L. Messori, A. Merlino, Cisplatin binding to human serum albumin: a structural study. Chem. Commun. 51(46), 9436–9439 (2015)
D. Esteban-Fernández, E. Moreno-Gordaliza, B. Cañas, M.A. Palacios, M.M. Gómez-Gómez, Analytical methodologies for metallomics studies of antitumor Pt-containing drugs. Metallomics 2(1), 19–38 (2010)
N.P. Farell, Platinum formulations as anticancer drugs clinical and pre-clinical studies. Curr. Top. Med. Chem. 11(21), 2623–2631 (2011)
Y. Wang, H. Wang, H. Li, H. Sun, Metallomic and metalloproteomic strategies in elucidating the molecular mechanisms of metallodrugs. Dalton Trans. 44(2), 437–447 (2015)
A. Divsalar, A. Saboury, R. Yousefi, A. Moosavi-Movahedi, H. Mansoori-Torshizi, Spectroscopic and cytotoxic studies of the novel designed palladium (II) complexes: β-Lactoglobulin and K562 as the targets. Int. J. Biol. Macromol. 40(4), 381–386 (2007)
A. Gholamian, A. Divsalar, M. Saiedifar, B. Ghalandari, A.A. Saboury, B. Koohshekan, Generation of reactive oxygen species via inhibition of liver catalase by oxalli-palladium: a spectroscopic and docking study. Process Biochem. 52, 165–173 (2017)
H. Mansoori-Torshizi, M. Islami-Moghaddam, A.A. Saboury, A microcalorimetry and spectroscopy study on the interaction of BSA with 2, 2′-bipyridine octylglycinato palladium (II) nitrate. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao 35(10), 886–890 (2003)
A. Divsalar, M.J. Bagheri, A.A. Saboury, H. Mansoori-Torshizi, M. Amani, Investigation on the interaction of newly designed anticancer Pd (II) complexes with different aliphatic tails and human serum albumin. J. Phys. Chem. B 113(42), 14035–14042 (2009)
N. Zhang, Y. Du, M. Cui, J. Xing, Z. Liu, S. Liu, Probing the interaction of cisplatin with cytochrome c by electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry. Anal. Chem. 84(14), 6206–6212 (2012)
L. Banci, I. Bertini, O. Blaževitš, V. Calderone, F. Cantini, J. Mao et al., Interaction of cisplatin with human superoxide dismutase. J. Am. Chem. Soc. 134(16), 7009–7014 (2012)
O. Abazari, Z. Shafaei, A. Divsalar, M. Eslami-Moghadam, B. Ghalandari, A.A. Saboury, Probing the biological evaluations of a new designed Pt(II) complex using spectroscopic and theoretical approaches: human hemoglobin as a target. J. Biomol. Struct. Dyn. 34(5), 1123–1131 (2016)
M.K. Zia, T. Siddiqui, S.S. Ali, A.A. Rehman, H. Ahsan, F.H. Khan, Chemotherapeutic drugs and plasma proteins: exploring new dimensions. Curr. Protein Pept. Sci. 19(10), 937–947 (2018)
U. Ndagi, N. Mhlongo, M.E. Soliman, Metal complexes in cancer therapy—an update from drug design perspective. Drug Des. Dev. Ther. 11, 599 (2017)
E.Z. Jahromi, A. Divsalar, A.A. Saboury, S. Khaleghizadeh, H. Mansouri-Torshizi, I. Kostova, Palladium complexes: new candidates for anti-cancer drugs. J. Iran. Chem. Soc. 13(5), 967–989 (2016)
M. Kantoury, M. Eslami Moghadam, A.A. Tarlani, A. Divsalar, Structure effect of some new anticancer Pt(II) complexes of amino acid derivatives with small branched or linear hydrocarbon chains on their DNA interaction. Chem. Biol. Drug Des. 88(1), 76–87 (2016)
U. Sahebi, A. Divsalar, Synergistic and inhibitory effects of propolis and aspirin on structural changes of human hemoglobin resulting from glycation: an in vitro study. J. Iran. Chem. Soc. 13(11), 2001–2011 (2016)
P.H. Schippers, H.P. Dekkers, Direct determination of absolute circular dichroism data and calibration of commercial instruments. Anal. Chem. 53(6), 778–782 (1981)
P. Manavalan, W.C. Johnson Jr., Variable selection method improves the prediction of protein secondary structure from circular dichroism spectra. Anal. Biochem. 167(1), 76–85 (1987)
G.M. Morris, R. Huey, W. Lindstrom, M.F. Sanner, R.K. Belew, D.S. Goodsell et al., AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J. Comput. Chem. 30(16), 2785–2791 (2009)
G. Wolber, A.A. Dornhofer, T. Langer, Efficient overlay of small organic molecules using 3D pharmacophores. J. Comput. Aided Mol. Des. 20(12), 773–788 (2006)
I. Petitpas, A.A. Bhattacharya, S. Twine, M. East, S. Curry, Crystal structure analysis of warfarin binding to human serum albumin anatomy of drug site I. J. Biol. Chem. 276(25), 22804–22809 (2001)
G. Fermi, M. Perutz, B. Shaanan, R. Fourme, The crystal structure of human deoxyhaemoglobin at 1.74 Å resolution. J. Mol. Biol. 175(2), 159–174 (1984)
M.F. Sanner, Python: a programming language for software integration and development. J. Mol. Graph. Model. 17(1), 57–61 (1999)
W. Humphrey, A. Dalke, K. Schulten, VMD: visual molecular dynamics. J. Mol. Graph. 14(1), 33–38 (1996)
A. Taheri-Kafrani, E. Asgari-Mobarakeh, A.-K. Bordbar, T. Haertlé, Structure–function relationship of β-lactoglobulin in the presence of dodecyltrimethyl ammonium bromide. Colloids Surf. B Biointerfaces 75(1), 268–274 (2010)
B. Ghalandari, A. Divsalar, A.A. Saboury, K. Parivar, β-Lactoglobulin nanoparticle as a chemotherapy agent carrier for oral drug delivery system. J. Iran. Chem. Soc. 12(4), 613–619 (2015)
M. Zaharia, R. Gradinaru, Interaction of human hemoglobin with methotrexate. J. Appl. Spectrosc. 82(2), 278–285 (2015)
P. Mandal, T. Ganguly, Fluorescence spectroscopic characterization of the interaction of human adult hemoglobin and two isatins, 1-methylisatin and 1-phenylisatin: a comparative study. J. Phys. Chem. B 113(45), 14904–14913 (2009)
P. Seal, J. Sikdar, A. Roy, R. Haldar, Acetaminophen interacts with human hemoglobin: optical, physical and molecular modeling studies. J. Biomol. Struct. Dyn. 35(6), 1307–1321 (2017)
L. Stryer, Intramolecular resonance transfer of energy in proteins. Biochim. Biophys. Acta 35, 242–244 (1959)
A. Divsalar, A. Saboury, A.A. Moosavi-Movahedi, Conformational and structural analysis of bovine β lactoglobulin-A upon interaction with Cr+3. Protein J. 25(2), 157–165 (2006)
Y. Sun, S. Wei, C. Yin, L. Liu, C. Hu, Y. Zhao et al., Synthesis and spectroscopic characterization of 4-butoxyethoxy-N-octadecyl-1, 8-naphthalimide as a new fluorescent probe for the determination of proteins. Bioorg. Med. Chem. Lett. 21(12), 3798–3804 (2011)
M. Ghali, Static quenching of bovine serum albumin conjugated with small size CdS nanocrystalline quantum dots. J. Lumin. 130(7), 1254–1257 (2010)
M.-F. Zhang, Z.-Q. Xu, Y.-S. Ge, F.-L. Jiang, Y. Liu, Binding of fullerol to human serum albumin: spectroscopic and electrochemical approach. J. Photochem. Photobiol. B 108, 34–43 (2012)
S. Tabassum, W.M. Al-Asbahy, M. Afzal, F. Arjmand, Synthesis, characterization and interaction studies of copper based drug with human serum albumin (HSA): spectroscopic and molecular docking investigations. J. Photochem. Photobiol. B 114, 132–139 (2012)
J. Ding, L. Yuan, L. Gao, J. Chen, Fluorescence quenching of a rhodamine derivative: selectively sensing Cu2+ in acidic aqueous media. J. Lumin. 132(8), 1987–1993 (2012)
X.M. He, D.C. Carter, Atomic structure and chemistry of human serum albumin. Nature 358(6383), 209 (1992)
E. Froehlich, J. Mandeville, C. Jennings, R. Sedaghat-Herati, H. Tajmir-Riahi, Dendrimers bind human serum albumin. J. Phys. Chem. B 113(19), 6986–6993 (2009)
A. Divsalar, A. Saboury, H. Mansoori-Torshizi, B. Hemmatinejad, Comparative and structural analysis of the interaction between β-lactoglobulin type A and B with a new anticancer component (2, 2/-bipyridin n-hexyl dithiocarbamatoPd (II) nitrate). Bull. Korean Chem. Soc. 27, 1801–1808 (2006)
A. Divsalar, A.A. Saboury, H. Mansoori-Torshizi, F. Ahmad, Design, synthesis, and biological evaluation of a new palladium (II) complex: β-lactoglobulin and K562 as targets. J. Phys. Chem. B 114(10), 3639–3647 (2010)
Y.-Q. Wang, H.-M. Zhang, G.-C. Zhang, W.-H. Tao, S.-H. Tang, Binding of brucine to human serum albumin. J. Mol. Struct. 830(1–3), 40–45 (2007)
C. N’Soukpoe-Kossi, R. Sedaghat-Herati, C. Ragi, S. Hotchandani, H. Tajmir-Riahi, Retinol and retinoic acid bind human serum albumin: stability and structural features. Int. J. Biol. Macromol. 40(5), 484–490 (2007)
Y.-J. Hu, H.-L. Yue, X.-L. Li, S.-S. Zhang, E. Tang, L.-P. Zhang, Molecular spectroscopic studies on the interaction of morin with bovine serum albumin. J. Photochem. Photobiol. B 112, 16–22 (2012)
F. Faridbod, M.R. Ganjali, B. Larijani, S. Riahi, A.A. Saboury, M. Hosseini et al., Interaction study of pioglitazone with albumin by fluorescence spectroscopy and molecular docking. Spectrochim. Acta A Mol. Biomol. Spectrosc. 78(1), 96–101 (2011)
J.T. Yang, C.S. Wu, H.M. Martinez, Calculation of protein conformation from circular dichroism. Methods Enzymol. 130, 208–269 (1986)
L. Yang, D. Huo, C. Hou, M. Yang, H. Fa, X. Luo, Interaction of monosulfonate tetraphenyl porphyrin (H2TPPS1) with plant-esterase: determination of the binding mechanism by spectroscopic methods. Spectrochim. Acta A Mol. Biomol. Spectrosc. 78(5), 1349–1355 (2011)
J. Ma, K. Chen, X. Zheng, M. Guo, J. Ma, Q. Tang et al., Spectroscopy study on the interaction of colchicine and human serum albumin. Guang pu xue yu guang pu fen xi = Guang pu 27(12), 2485–2489 (2007)
J. Xi, R. Guo, Interactions between flavonoids and hemoglobin in lecithin liposomes. Int. J. Biol. Macromol. 40(4), 305–311 (2007)
Acknowledgements
Notably, the Research Council of Kharazmi University would be greatly acknowledged for their financial support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
As a result of this, it is declared that we do not have any conflicts of interest regarding the present research.
Rights and permissions
About this article
Cite this article
Abazari, O., Shafaei, Z., Divsalar, A. et al. Interaction of the synthesized anticancer compound of the methyl-glycine 1,10-phenanthroline platinum nitrate with human serum albumin and human hemoglobin proteins by spectroscopy methods and molecular docking. J IRAN CHEM SOC 17, 1601–1614 (2020). https://doi.org/10.1007/s13738-020-01879-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13738-020-01879-1